Comparative Efficacy of Pharmacologic Interventions in Preventing Relapse of Crohn’s Disease After Surgery: A Systematic Review and Network Meta-analysis
Open Access
- 1 January 2015
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 148 (1) , 64-76.e2
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Ciprofloxacin for the Prevention of Postoperative Recurrence in Patients with Crohnʼs DiseaseInflammatory Bowel Diseases, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Network meta‐analysis for indirect treatment comparisonsStatistics in Medicine, 2002
- A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study GroupGastroenterology, 1997
- Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohnʼs diseaseEuropean Journal of Gastroenterology & Hepatology, 1996
- Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's diseaseGastroenterology, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- The Long-term Prophylactic Effect of Salazosulfapyridine (SalazopyrinR) in Primarily Resected Patients with Crohn's DiseaseScandinavian Journal of Gastroenterology, 1978